Description

This Computer Simulation Assessment Tool (CSAT) helps you navigate the complex clinical relationship and presentation of fatigue and depression.

In order to provide optimal care, it is critical for mental health professionals to effectively assess the presence of fatigue in patients who have depression. Fatigue is associated with depression in a variety of ways. It can be a prodromal symptom and risk factor for development of depression. It can also be a core symptom of depression, a residual symptom, and a risk factor for recurrence. Fatigue can also be a side effect of antidepressant treatment.

Failure to recognize side effects can result in prolonged morbidity as well as medication non-adherence.

This simulation presents you with a real-world, case-based situation that tests your clinical skill set. Review patient information and video vignettes. Make clinical decisions based on those virtual clinical encounters. And access rating scales and other resources that provide guidance on recommended clinical screening methods and optimal treatment strategies.

To download the CPFQ Rating Scale, visit:www.mghcme.org/CPFQratingscale.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Recognize the limitations of current antidepressant therapy, and monitor patients for persisting, residual symptoms.
  • Identify fatigue in depressed patients and assess fatigue symptoms using clinical interviews and formal screening tools.
  • Employ appropriate pharmacologic treatments to treat or prevent fatigue in patients with depression.

Target Audience

Psychiatrists, Psychologists, Primary Care, Internal and Family Care Physicians, Nurses and Other Allied Healthcare Professionals.

Faculty

  • Director of Research, Depression Clinical and Research Program
    Massachusetts General Hospital
    Associate Professor of Psychiatry
    Harvard Medical School

Educational Support

This program has received support in the form of educational grants from Janssen Global Services, LLC, Sunovion Pharmaceuticals, Inc., and Takeda Pharmaceuticals International, Inc.

Computer Simulation Assessment Tools

We offer several free Computer Simulation Assessment Tools. See the full list at the link below.

View our online computer simulation assessment tools course offerings

CME Information

Release Date: December 30, 2015
Expiration Date: December 30, 2017
Review Date: December 20, 2016 by Robert Althoff, MD


CREDIT

TYPE

ACCREDITATION STATEMENT

DESIGNATION STATEMENT

1

AMA PRA Category 1 CreditTM

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

McLean Hospital designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

1

Psychologists CE Credit

The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

This offering meets the criteria for 1 continuing education credit for psychologists.

1

Nursing Contact Hours

Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

This program meets the requirements of the Massachusetts Board of Registration in Nursing at (244 CMR 5.00) for 1 contact hours of nursing continuing education credit.

1

(self-claim)

Other Professions

Other Providers can claim a Participation Certificate upon successful completion of this course.

Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 CreditsTM associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 CreditsTM may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.


Policy on Faculty and Provider Disclosure

It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

Planner Disclosures

The following planners and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:

David H. Rubin, MD, Reviewer
Jane Pimental, MPH

The following planners and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:

Michael Hirsch, MD
Royalties: UpToDate

Susan E. Sprich, PhD
Royalties: Oxford University Press (for co-authoring treatment manual and client workbook), Springer (for editing book)


Speaker Disclosures

The following speakers and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:

Brian Dongelewic, role play actor
Jane Lanier, MD,role play actor

The following speakers and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:

David Mischoulon, MD

Research Support (principal investigator): Bowman Family Foundation, FisherWallace, Nordic Naturals, Methylation Sciences, Inc. (MSI), and PharmoRx Therapeutics

Author Royalties: Lipponcott, Williams, and Wilkins("Natural Medications for Psychiatric Disorders: Considering the Alternatives," Mischoulon and Rosenbaum, Eds.)


Educational Support

This program has received support in the form of educational grants from Janssen Global Services, LLC, Sunovion Pharmaceuticals, Inc., and Takeda Pharmaceuticals International, Inc.